
Chemical and Pharmaceutical Bulletin p. 1332 - 1337 (2000)
Update date:2022-09-26
Topics:
Wang
Soper
Dirr
DeLong
De
Wos
A novel class of saturated prostaglandin F(2α) sulfonamide analogs have been synthesized and evaluated in the human FP receptor binding assay for potential use in the treatment of osteoporosis. These compounds have been modified at the C1 carboxylic acid moiety and at the C16 - C20 region of the prostaglandin. Based on the structure-activity relationships, it was found that at C1, the aryl sulfonamide analogs possessed greater affinity for the hFP receptor when compared to alkyl sulfonamides. When the sulfonamide was introduced into the C16 - C20 region (omega chain) of the prostaglandin, a significant reduction in binding was observed. These results are discussed within the framework of a proposed model for the human FP receptor.
View MoreGoldwills Pharmaceuticals Co., Ltd.
Contact:0916-2237889 13991621155
Address:North Suburb of Hanzhong city, Shaanxi Province
Jiangsu Feymer Technology Co., Ltd.
Contact:+86-512-58110132
Address:Fenghuang Town, Zhangjiagang City, Jiangsu Province, China
Xinjiang Zhongtai Chemical Co., Ltd.
Contact:+86-991-8788172
Address:NO.78 XISHAN RD.URUMQI,CHINA
Contact:021-36356756
Address:Room601,Building No.14,280 Yangcheng Road,Shanghai
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Doi:10.1039/c39860000088
(1986)Doi:10.1002/adsc.202000499
(2020)Doi:10.1080/00397910801929382
(2008)Doi:10.1039/b714735j
(2008)Doi:10.1007/BF00842975
(1985)Doi:10.1007/BF00758610
(1986)